Literature DB >> 16490750

RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.

A R Pettit1, N C Walsh, C Manning, S R Goldring, E M Gravallese.   

Abstract

OBJECTIVES: Receptor activator of NF-kappaB ligand (RANKL) and osteoprotegerin (OPG) have been demonstrated to be critical regulators of osteoclast generation and activity. In addition, RANKL has been implicated as an important mediator of bone erosion in rheumatoid arthritis (RA). However, the expression of RANKL and OPG at sites of pannus invasion into bone has not been examined. The present study was undertaken to further elucidate the contribution of this cytokine system to osteoclastogenesis and subsequent bone erosion in RA by examining the pattern of protein expression for RANKL, OPG and the receptor activator of NF-kappaB (RANK) in RA at sites of articular bone erosion.
METHODS: Tissues from 20 surgical procedures from 17 patients with RA were collected as discarded materials. Six samples contained only synovium or tenosynovium remote from bone, four samples contained pannus-bone interface with adjacent synovium and 10 samples contained both synovium remote from bone and pannus-bone interface with adjacent synovium. Immunohistochemistry was used to characterize the cellular pattern of RANKL, RANK and OPG protein expression immediately adjacent to and remote from sites of bone erosion.
RESULTS: Cellular expression of RANKL protein was relatively restricted in the bone microenvironment; staining was focal and confined largely to sites of osteoclast-mediated erosion at the pannus-bone interface and at sites of subchondral bone erosion. RANK-expressing osteoclast precursor cells were also present in these sites. OPG protein expression was observed in numerous cells in synovium remote from bone but was more limited at sites of bone erosion, especially in regions associated with RANKL expression.
CONCLUSIONS: The pattern of RANKL and OPG expression and the presence of RANK-expressing osteoclast precursor cells at sites of bone erosion in RA contributes to the generation of a local microenvironment that favours osteoclast differentiation and activity. These data provide further evidence implicating RANKL in the pathogenesis of arthritis-induced joint destruction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490750     DOI: 10.1093/rheumatology/kel045

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  43 in total

1.  VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.

Authors:  Qian Zhang; Ruolin Guo; Yan Lu; Lan Zhao; Quan Zhou; Edward M Schwarz; Jing Huang; Di Chen; Zheng-Gen Jin; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

2.  sRANKL and OPG in serum and synovial fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis.

Authors:  Gert E Hein; Marit Meister; Peter Oelzner; Sybille Franke
Journal:  Rheumatol Int       Date:  2008-01-03       Impact factor: 2.631

Review 3.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

4.  The impact of serial radon and hyperthermia exposure in a therapeutic adit on pivotal cytokines of bone metabolism in rheumatoid arthritis and osteoarthritis.

Authors:  Uwe Lange; Gabriel Dischereit; Ingo Tarner; Klaus Frommer; Elena Neumann; Ulf Müller-Ladner; Bernhard Kürten
Journal:  Clin Rheumatol       Date:  2016-04-06       Impact factor: 2.980

5.  Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.

Authors:  Dallas Jones; Laurie H Glimcher; Antonios O Aliprantis
Journal:  J Clin Invest       Date:  2011-07-01       Impact factor: 14.808

6.  Interleukin-27 suppresses osteoclastogenesis via induction of interferon-γ.

Authors:  Jin-Sil Park; Young Ok Jung; Hye-Joa Oh; Seong Jeong Park; Yu-Jung Heo; Chang-Min Kang; Seung-Ki Kwok; Ji Hyeon Ju; Kyung Su Park; Mi-La Cho; Young-Chul Sung; Sung-Hwan Park; Ho-Youn Kim
Journal:  Immunology       Date:  2012-12       Impact factor: 7.397

7.  Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.

Authors:  Kazuhiro Maeda; Yasuhiro Kobayashi; Nobuyuki Udagawa; Shunsuke Uehara; Akihiro Ishihara; Toshihide Mizoguchi; Yuichiro Kikuchi; Ichiro Takada; Shigeaki Kato; Shuichi Kani; Michiru Nishita; Keishi Marumo; T John Martin; Yasuhiro Minami; Naoyuki Takahashi
Journal:  Nat Med       Date:  2012-02-19       Impact factor: 53.440

8.  Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection.

Authors:  Weiqiang Chen; Suan-Sin Foo; Adam Taylor; Aleksei Lulla; Andres Merits; Linda Hueston; Mark R Forwood; Nicole C Walsh; Natalie A Sims; Lara J Herrero; Suresh Mahalingam
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

9.  Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis.

Authors:  Anna Neve; Addolorata Corrado; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2013-07-04       Impact factor: 3.984

10.  Suppression of Peripheral Pain by Blockade of Voltage-Gated Calcium 2.2 Channels in Nociceptors Induces RANKL and Impairs Recovery From Inflammatory Arthritis in a Mouse Model.

Authors:  Uta Baddack; Silke Frahm; Beatriz Antolin-Fontes; Jenny Grobe; Martin Lipp; Gerd Müller; Ines Ibañez-Tallon
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.